UTHR United Therapeutics Corporation

NASDAQ
$559.10

United Therapeutics Corporation (UTHR) Earnings News

Earnings press releases, previews and reviews for United Therapeutics Corporation (UTHR), newest first. Our most recent is review: United Therapeutics Misses on EPS as Thymmune Charge Obscures Record Revenue and a Tyvaso Reacceleration.